TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32867986

Group type: EXPERIMENTAL
Intervention: Standard BW treatment with 12L:12D rearing photoschedule
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: High BW treatment
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 8L:16D rearing photoschedule
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 10L:14D rearing photoschedule
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 12L:12D rearing photoschedule
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Model IV
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Model I
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: ME requirement for ADG
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: ME requirement for EM
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Models II-IV
Number of subjects: 180
Study: 35795456

Group type: EXPERIMENTAL
Intervention: Nontraditional guitar instruction
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nontraditional guitar instruction (Group 1 exposed to intervention first)
Number of subjects: 26
Study: 32249746

Group type: EXPERIMENTAL
Intervention: Experimental condition (universal prevention program)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 308
Study: 36482616

Group type: EXPERIMENTAL
Intervention: Long-term electrocardiogram (ECG) screening for atrial fibrillation (AF)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 89
Study: 33749643

Group type: EXPERIMENTAL
Intervention: Folic acid (0.8 mg/day) + DHA (800 mg/day)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Folic acid (0.8 mg/day)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: DHA (800 mg/day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 32855064

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35752776

Group type: EXPERIMENTAL
Intervention: High-fidelity mannequin training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low-fidelity mannequin training
Number of subjects: 28
Study: 32725783

Group type: EXPERIMENTAL
Intervention: AP30663
Number of subjects: 47
Study: 35212621

Group type: EXPERIMENTAL
Intervention: Peer-delivered intervention by Peer Navigators
Number of subjects: 68
Study: 32220771

Group type: EXPERIMENTAL
Intervention: Mannitol plus hypertonic saline combination (MHS)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Hypertonic saline monotherapy (HS)
Number of subjects: 326
Study: 35984626

Group type: EXPERIMENTAL
Intervention: Single 200 mg/2 mL subcutaneous injection of tildrakizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two 100 mg/1 mL subcutaneous injections of tildrakizumab
Number of subjects: 0
Study: 32980245

Group type: EXPERIMENTAL
Intervention: Family-based economic intervention
Number of subjects: 358
Study: 34365016

Group type: EXPERIMENTAL
Intervention: 4 weeks of in-person group sessions plus 11 months of eHealth communication
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: In-person group sessions alone
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: eHealth alone
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control
Number of subjects: 241
Study: 32727304

Group type: EXPERIMENTAL
Intervention: Nutritional status assessment
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Malnutrition
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Prevalence of malnutrition after six months
Number of subjects: 5
Study: 32130136

Group type: EXPERIMENTAL
Intervention: SNI-TP (Social Networking Intervention with Time Pressure)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: SNI+TP (Social Networking Intervention without Time Pressure)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: SNI+TP
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: SNI-TP
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Intervention groups
Number of subjects: 205
Study: 34752667

Group type: EXPERIMENTAL
Intervention: Terbinafine 10% nail lacquer
Number of subjects: 953

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Amorolfine 5%
Number of subjects: 953
Study: 35991113

Group type: EXPERIMENTAL
Intervention: History first (HF)
Number of subjects: 52

Group type: COMPARATOR
Intervention: EKG first (EKGF)
Number of subjects: 52
Study: 36405443

Group type: EXPERIMENTAL
Intervention: Flanged intrascleral IOL fixation using the Yamane technique (Group A)
Number of subjects: 35

Group type: COMPARATOR
Intervention: 4-point transscleral fixation of IOL using Gore-Tex suture (Group B)
Number of subjects: 35
Study: 33145441

Group type: EXPERIMENTAL
Intervention: myCOPD app
Number of subjects: 41

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 41
Study: 34968002

Group type: EXPERIMENTAL
Intervention: Dissection
Number of subjects: 77

Group type: COMPARATOR
Intervention: Prosection
Number of subjects: 77
Study: 32698986

Group type: EXPERIMENTAL
Intervention: Integrated securement dressing
Number of subjects: 109

Group type: COMPARATOR
Intervention: Simple polyurethane dressing
Number of subjects: 109
Study: 32513289

Group type: EXPERIMENTAL
Intervention: Ivermectin 400 μg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34932192

Group type: EXPERIMENTAL
Intervention: Novel drug candidate for nocturnal polyuria
Number of subjects: 302
Study: 32753750

Group type: EXPERIMENTAL
Intervention: Cooling therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 45
Study: 34991562

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 130
Study: 33740113

Group type: EXPERIMENTAL
Intervention: glasdegib + low-dose cytarabine (LDAC)
Number of subjects: 96
Study: 32130166

Group type: EXPERIMENTAL
Intervention: Mobile phone-based support intervention
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard postabortion family planning care
Number of subjects: 1000
Study: 36273386

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention
Number of subjects: 842
Study: 33035103

Group type: COMPARATOR
Intervention: Mechanical thromboprophylaxis only (group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined mechanical and chemical thromboprophylaxis (group B)
Number of subjects: 150
Study: 35559512

Group type: EXPERIMENTAL
Intervention: COX inhibition (10 mM ketorolac)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: EDHF inhibition (50 mM tetraethylammonium, TEA)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (lactated Ringer's)
Number of subjects: 5
Study: 32115341

Group type: EXPERIMENTAL
Intervention: Experimental group (early and intense lower extremity training using a recumbent cycle ergometer)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (conventional treatment)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study: 33885348

Group type: EXPERIMENTAL
Intervention: English intervention program
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 124
Study: 36074476

Group type: EXPERIMENTAL
Intervention: Centrifugal-flow LVAD (HeartMate 3)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Axial-flow LVAD (HeartMate II)
Number of subjects: 295
Study: 35778255

Group type: EXPERIMENTAL
Intervention: First-person abortion video stories (n = 460)
Number of subjects: 886

Group type: COMPARATOR
Intervention: Nature videos (n = 426)
Number of subjects: 886
Study: 33828182

Group type: EXPERIMENTAL
Intervention: summary data‐based MR (SMR) method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR Steiger method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: simple and yet more powerful alternative to SMR
Number of subjects: 0
Study: 35100785

Group type: EXPERIMENTAL
Intervention: Standard pediatric CPR
Number of subjects: 21

Group type: COMPARATOR
Intervention: Walking pediatric CPR
Number of subjects: 21
Study: 32484630

Group type: EXPERIMENTAL
Intervention: ALA 2x
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: ALA 3x
Number of subjects: 166

Group type: COMPARATOR
Intervention: Vehicle (VEH) pooled (VEH 2x + VEH 3x)
Number of subjects: 166
Study: 32173802

Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg 30 minutes before induction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (physiological saline)
Number of subjects: 60
Study: 33927086

Group type: EXPERIMENTAL
Intervention: TAF/emtricitabine + dolutegravir (TAF/FTC + DTG)
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: tenofovir disoproxil fumarate/FTC + dolutegravir (TDF/FTC + DTG)
Number of subjects: 1053

Group type: COMPARATOR
Intervention: tenofovir disoproxil fumarate/FTC + efavirenz (TDF/FTC/EFV)
Number of subjects: 1053
Study: 33081758

Group type: EXPERIMENTAL
Intervention: Discontinuing oxytocin during the active phase of labor
Number of subjects: 2475

Group type: COMPARATOR
Intervention: Continuing oxytocin infusion
Number of subjects: 2475
Study: 36102339

Group type: EXPERIMENTAL
Intervention: Communication training (2-hour virtual training)
Number of subjects: 15
Study: 34776918

Group type: EXPERIMENTAL
Intervention: Randomized reaching practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First-order model with a constant learning rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Practiced movement direction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unpracticed movement directions
Number of subjects: 0
Study: 36068554

Group type: EXPERIMENTAL
Intervention: Continuous Renal Replacement Therapy (CRRT)
Number of subjects: 2542

Group type: COMPARATOR
Intervention: Intermittent Hemodialysis (IHD)
Number of subjects: 2542

Group type: EXPERIMENTAL
Intervention: ATN treatment protocol (among CRRT-first patients)
Number of subjects: 2542
Study: 36191321

Group type: EXPERIMENTAL
Intervention: Eptinezumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33582525

Group type: EXPERIMENTAL
Intervention: active cTBS
Number of subjects: 33

Group type: COMPARATOR
Intervention: sham
Number of subjects: 33
Study: 32874106

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) - computerized exercise program, 3 times per week for 6 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Inactive control group (CON)
Number of subjects: 44
Study: 35886419

Group type: EXPERIMENTAL
Intervention: Muscle relaxation intervention
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Hypnosis intervention
Number of subjects: 170

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 170

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: All interventions (muscle relaxation, hypnosis, active control)
Number of subjects: 170
Study: 34967170

Group type: EXPERIMENTAL
Intervention: PPR-001
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35970431

Group type: EXPERIMENTAL
Intervention: 0.003% AR-15512
Number of subjects: 122

Group type: COMPARATOR
Intervention: 0.0014% AR-15512
Number of subjects: 122

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 122
Study: 34031020

Group type: EXPERIMENTAL
Intervention: Clopidogrel monotherapy
Number of subjects: 833

Group type: COMPARATOR
Intervention: DAPT
Number of subjects: 833
Study: 35215467

Group type: EXPERIMENTAL
Intervention: Zinc biofortified flour
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control flour (not specified)
Number of subjects: 72
Study: 32383748

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (15 mg for men and 12 mg for women, taken daily by mouth for 18 months)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 254
Study: 34208363

Group type: EXPERIMENTAL
Intervention: Support Group (SG) - 18 months of dietary and psychological support including Ten Top Tips (TTT), cognitive behavioral therapy (CBT), motivational interviewing (MI), nutritional education, and physical activity assessment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control Group (CG) - no additional care
Number of subjects: 36
Study: 32201442

Group type: COMPARATOR
Intervention: Methotrexate 7.5 mg/week for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pioglitazone 15 mg tablets once daily for 12 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of methotrexate and pioglitazone
Number of subjects: 90
Study: 35347091

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acustimulation (TEA) at acupuncture point ST36 (chronic study)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acustimulation (TEA) at acupuncture point ST36 (acute study)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acustimulation (TEA) at acupuncture point ST36 (acute and chronic studies)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham-TEA (chronic study)
Number of subjects: 53
Study: 34528557

Group type: EXPERIMENTAL
Intervention: Accelerated concurrent chemoradiotherapy (ART) with 50 Gy/25#/4 weeks and cisplatin 40 mg/m2 weekly
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional concurrent chemoradiotherapy (control) with 50 Gy/25#/5 weeks and cisplatin 40 mg/m2 weekly
Number of subjects: 90
Study: 32891126

Group type: EXPERIMENTAL
Intervention: Virtual diabetes clinic
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual diabetes care
Number of subjects: 100
Study: 35790961

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 573

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 573
Study: 33406277

Group type: EXPERIMENTAL
Intervention: ACT-1004-1239 (doses 1-200 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ACT-1004-1239
Number of subjects: 48
Study: 33441798

Group type: EXPERIMENTAL
Intervention: Lavender aroma during sleep
Number of subjects: 9
Study: 33051029

Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy (ICBT) delivered in research settings
Number of subjects: 68

Group type: COMPARATOR
Intervention: Individual cognitive behavioral therapy (ICBT) delivered in community settings
Number of subjects: 68
Study: 35833274

Group type: EXPERIMENTAL
Intervention: MTX + adalimumab
Number of subjects: 180

Group type: COMPARATOR
Intervention: MTX + placebo
Number of subjects: 180
Study: 33782020

Group type: EXPERIMENTAL
Intervention: Unite for a Better Life (UBL) intervention
Number of subjects: 6770
Study: 32569033

Group type: EXPERIMENTAL
Intervention: Double-layer Stockinette (29 patients)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard 2- to 3-layer Webril (27 patients)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Webril group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Stockinette group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Double-layer Stockinette
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard 2- to 3-layer Webril
Number of subjects: 56
Study: 33886402

Group type: EXPERIMENTAL
Intervention: Visual-based infographics with a day frame
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Text-based messages with a year frame
Number of subjects: 268

Group type: COMPARATOR
Intervention: Visual-based infographics with a year frame
Number of subjects: 268

Group type: COMPARATOR
Intervention: Text-based messages with a day frame
Number of subjects: 268
Study: 32293992

Group type: EXPERIMENTAL
Intervention: Single pigtail suture stent (SPSS)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Double-pigtail ureteral stent (DPUS)
Number of subjects: 130
Study: 33435992

Group type: EXPERIMENTAL
Intervention: Nurse-led support (intensive arm)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Standard care (standard arm)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Combined standard and observational arms
Number of subjects: 323
Study: 32481255

Group type: EXPERIMENTAL
Intervention: Naesohwajung-tang (NHT)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 35995732

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 80
Study: 33789437

Group type: EXPERIMENTAL
Intervention: Parent-implemented augmented language intervention using AAC
Number of subjects: 109

Group type: COMPARATOR
Intervention: Traditional spoken language intervention
Number of subjects: 109
Study: 33055589

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin and docetaxel, followed by concomitant chemoradiation therapy with cisplatin, docetaxel, and 45Gy, plus adjuvant cetuximab.
Number of subjects: 259
Study: 34617827

Group type: EXPERIMENTAL
Intervention: DA + SDM video
Number of subjects: 0
Study: 33989969

Group type: EXPERIMENTAL
Intervention: Naltrexone/Bupropion (NB) + antidepressants
Number of subjects: 8910

Group type: EXPERIMENTAL
Intervention: Naltrexone/Bupropion (NB) without antidepressants
Number of subjects: 8910

Group type: COMPARATOR
Intervention: Placebo + antidepressants
Number of subjects: 8910

Group type: COMPARATOR
Intervention: Placebo without antidepressants
Number of subjects: 8910
Study: 33214579

Group type: EXPERIMENTAL
Intervention: Fat-dissociation method (FM)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional palpation method (PM)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Fat-dissociation method (FM) and Conventional palpation method (PM)
Number of subjects: 130
Study: 34269720

Group type: EXPERIMENTAL
Intervention: Dexamethasone (16 mg) and 20% albumin (100 mL) at induction of anesthesia, then 200 mL of 20% albumin with each subsequent 1000 mL of crystalloid administered (Dex‐Alb group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Crystalloid fluid only with no dexamethasone (control group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Dexamethasone and albumin (Dex‐Alb group)
Number of subjects: 72
Study: 32009651

Group type: EXPERIMENTAL
Intervention: Anchor binders selected from a combinatorial library screened with a biotinylated ligand and validated with unlabeled ligand by bio-layer interferometry (BLI).
Number of subjects: 1000000000

Group type: EXPERIMENTAL
Intervention: Dimerization binders selected from anchor binder-ligand complexes for positive screening and unbound anchor binders for negative screening.
Number of subjects: 1000000000
Study: 35534614

Group type: EXPERIMENTAL
Intervention: 12-week foot-ankle exercise program
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 78
Study: 32035892

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (25, 37.5, or 50 mg twice daily)
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8000
Study: 35500976

Group type: EXPERIMENTAL
Intervention: GM active trigger point dry needling (TrP‐DN) combined with conventional physiotherapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 29
Study: 32173107

Group type: EXPERIMENTAL
Intervention: Full MTM (complete MTM process)
Number of subjects: 1452

Group type: EXPERIMENTAL
Intervention: Partial MTM (incomplete MTM process)
Number of subjects: 1452

Group type: COMPARATOR
Intervention: No MTM
Number of subjects: 1452
Study: 34611715

Group type: EXPERIMENTAL
Intervention: Presence of any of seven symptoms for detecting influenza
Number of subjects: 2639

Group type: EXPERIMENTAL
Intervention: Symptom severity model including cough, fever, muscle aches, sweating and/or chills, moderate to severe overall disease, age, abdominal pain, and sore throat
Number of subjects: 2639
Study: 34118231

Group type: EXPERIMENTAL
Intervention: Asian applicants
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: URM applicants
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: White applicants
Number of subjects: 342
Study: 33170590

Group type: EXPERIMENTAL
Intervention: Low-Temperature Plasma (LTP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Graft Stability (GS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conjunctival Autograft Inflammation (CAI)
Number of subjects: 60
Study: 35877195

Group type: EXPERIMENTAL
Intervention: Favipiravir oral solution (200 mg/15 mL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Favipiravir tablet (200 mg)
Number of subjects: 24
Study: 32686253

Group type: EXPERIMENTAL
Intervention: PCSK9 levels on day 1
Number of subjects: 958

Group type: EXPERIMENTAL
Intervention: PCSK9 levels across quartiles
Number of subjects: 958

Group type: EXPERIMENTAL
Intervention: PCSK9 levels and PTX3 correlation
Number of subjects: 958
Study: 32925999

Group type: COMPARATOR
Intervention: Open flap debridement with no further treatment (Group 1, n = 10)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Piezoelectric contouring of the furcation roof (Group 2, n = 10)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Piezoelectric contouring of the furcation roof and bone grafting (Group 3, n = 9)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Piezoelectric contouring of the furcation roof and bone grafting with coronally positioned flap (Group 4, n = 10)
Number of subjects: 25
Study: 35739502

Group type: EXPERIMENTAL
Intervention: LUS‐monitored management (LUS‐m)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care management (SC‐m)
Number of subjects: 0
Study: 32696839

Group type: EXPERIMENTAL
Intervention: Involuntary breath stacking (IBS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Voluntary breath stacking (VBS)
Number of subjects: 20
Study: 36199782

Group type: EXPERIMENTAL
Intervention: Razumab (research group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Compaq (control group)
Number of subjects: 60
Study: 33462582

Group type: EXPERIMENTAL
Intervention: Azithromycin 1 g orally once weekly for 3 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily for 21 days
Number of subjects: 125
Study: 36484191

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (once a day, 6 times a week for 5 weeks, total of 30 times)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops with routine cleaning of eyelid margin and hot compress of eyes
Number of subjects: 80
Study: 33190133

Group type: EXPERIMENTAL
Intervention: ECC cycling training
Number of subjects: 24

Group type: COMPARATOR
Intervention: CON cycling training
Number of subjects: 24